Back to Journals » Clinical and Experimental Gastroenterology » Volume 3
Review
Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,177 | Dovepress* | 7,177+ | 2,191 | 9,368 | |
Totals | 7,177 | 2,191 | 9,368 | ||
*Since 12 May 2010 +Since July 2016 |
View citations on Google Scholar